Adial Pharmaceuticals Inc. Plunges 14.63% Amid Market Volatility

On July 11, 2025, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) experienced a significant drop of 14.63% in pre-market trading, reflecting ongoing market volatility and investor sentiment.

Adial Pharmaceuticals Inc. has been experiencing substantial price fluctuations, with a notable 28.61% loss in regular trading hours on July 10, 2025. This volatility is part of a broader trend that has seen the stock price fluctuate significantly over the past few weeks. The stock has shown a 66.67% gain over the last two weeks, indicating a highly volatile market environment.

Technical indicators suggest a mixed outlook for Adial Pharmaceuticals Inc. The stock has received a buy signal from the 3-month Moving Average Convergence Divergence (MACD), but there are also negative signals from the long-term moving average, which holds a general sell signal. This divergence indicates potential resistance at $0.471 and support at $0.335, suggesting a cautious approach for investors.

Analysts have upgraded their evaluation of Adial Pharmaceuticals Inc. from a Strong Sell to a Sell candidate, reflecting the stock's recent performance and technical indicators. The predicted fair opening price for July 11, 2025, is $0.381, which is 7.08% lower than the previous closing price. This prediction aligns with the overall negative sentiment surrounding the stock.